Pursuant to Rule 13d-1(k)(1) under the
Securities Exchange Act of 1934, as amended, the undersigned hereby consent to the joint filing on their behalf of a
single Schedule 13G and any amendment thereto, with respect to the beneficial ownership by each of the undersigned of the
Ordinary Shares of BioLineRx Ltd. The undersigned hereby further agree that this Joint Filing Agreement be included as an
exhibit to such statement and any such amendment. The undersigned acknowledge that each shall be responsible for the timely
filing of such amendments, and for the completeness and accuracy of the information concerning the others. The
undersigned hereby further agree that this Joint Filing Agreement may be executed in any number of counterparts, each of
which when so executed shall be deemed to be an original, but all of which counterparts shall together constitute one and the
same instrument.

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of February 16, 2016.